T2 Biosystems, Inc. (TTOO) News
Filter TTOO News Items
TTOO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest TTOO News From Around the Web
Below are the latest news stories about T2 BIOSYSTEMS INC that investors may wish to consider to help them evaluate TTOO as an investment opportunity.
Get Out Now! 7 Stocks That Are Destined to DieLooking to optimize your portfolio? |
T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumLEXINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NY. Management is scheduled to present on Thursday, November 16, 2023, at 8:00am ET. Interested parties may access a live and recorded webcast of the presentation |
TTOO Stock Alert: T2 Biosystems Regains Nasdaq ComplianceTTOO stock is back above $1 and is now officially in compliance with Nasdaq's minimum bid price requirement of $1. |
T2 Biosystems Regains Compliance with Nasdaq Listing RequirementsLEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that on October 31, 2023 it received written notice from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Lis |
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 ConferenceData demonstrates speed, accuracy, and clinical benefits of the T2Dx Instrument and T2 Biosystems’ sepsis panels, including encouraging early detection data for T2Resistance PanelLEXINGTON, Mass., Oct. 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted four new studies supporting the T2Bacteria® Panel, the T2Candida® Panel and the T2Resistance® Panel that were recently pres |
T2 Biosystems Announces Amendment and Extension of CRG Term Loan AgreementLEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the successful amendment and extension to its Term Loan Agreement with CRG Servicing LLC (“CRG”). The amendment extends both the interest-only period and the maturity date by one year from December 31, 2024 to December 31, 2025, and permanently reduces the minimum cash covenant from $5,000,000 to $500,00 |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday! |
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2023 Earnings Call TranscriptT2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2023 Earnings Call Transcript October 12, 2023 Operator: Greetings. Welcome to T2 Biosystems Preliminary Third Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. […] |
Why Is T2 Biosystems (TTOO) Stock Down 48% Today?TTOO stock is continuing its plunge after T2 Biosystems reported preliminary third-quarter earnings, missing on revenue. |
Why Shares of T2 Biosystems Are Falling FridayShares of T2 Biosystems (NASDAQ: TT00) were down more than 46% as of 10:45 a.m. on Friday after the healthcare company announced preliminary third-quarter earnings and a reverse stock split on Thursday. T2 Biosystems is a diagnostics company that focuses on detecting sepsis-causing pathogens and antibiotic resistance genes. |